The linearly decreasing convergence factor a. حسب Junhao Wei (6816803)

The results of linear mixed model. حسب Soheila Qanbari (20455173)

الموضوعات:

Reduction of NPIs by >50% may result increased transmission and significant mortality. حسب Benjamin U. Hoffman (5470583)

Contact structure can have a significant impact on the population immunity threshold. حسب Simon Bauer (11378195)

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. حسب Soheila Qanbari (20455173)

الموضوعات:

Trajectory scores decrease during learning. حسب Chenguang Zhang (457185)

"…Black lines indicate linear fits. We observed significant decreasing trends (*<i>p <</i> 0.05, * * <i>p <</i> 0.001), except for the left target for Monkey T and the downwards target for Monkey K.…"

The scatterplot, linear regression equation, 95% confidence band, and <i>p</i>-value for the oxidation-reduction potential (ORP) in millivolts (mV) versus pH. حسب Seth H. Frisbie (7821866)

الموضوعات: "…specific conductance increases…"

The summarized graph for the values of the coefficients of significant linear trends. حسب Ekaterina Ivanova (230383)

Crosslinking decreases the alignment of fibers associated with individual cells migrating out of spheroids. حسب Michael Pamonag (12295175)

Table1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.DOCX حسب Juan Martínez (4474276)

Brain areas with significant rCBF increase in within-group comparisons in each group. حسب Yutaro Mori (3125268)

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

DataSheet1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.PDF حسب Juan Martínez (4474276)

Statistically significant linear increase in use of antidepressants during the observed time period. حسب Jelena Filimonovic (22305307)

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات: